M MODAL THERAPEUTICS Trademark
Trademark Overview
On Wednesday, September 4, 2024, a trademark application was filed for M MODAL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the M MODAL THERAPEUTICS trademark a serial number of 98732499. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, March 18, 2025. This trademark is owned by FORESITE CAPITAL MANAGEMENT, LLC. The M MODAL THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceuticals research and development; Scientific and medical research and information services in the field of pharmaceutical development; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Research and development of therapeutic drugs for the prevention or treatment of human diseases; Scientific research in the field of drug discovery and development for others; Biomedical research services; Scientific research; Preclinical development of therapeutic product
General Information
| Serial Number | 98732499 |
| Word Mark | M MODAL THERAPEUTICS |
| Filing Date | Wednesday, September 4, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Tuesday, March 18, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of a stylized letter "M" with a mirrored shadow effect within a circular border. To the right of the circular border, the word "MODAL" appears in uppercase letters, and the word "Therapeutics" appears below "MODAL" in smaller title case letters. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Pharmaceuticals research and development; Scientific and medical research and information services in the field of pharmaceutical development; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Research and development of therapeutic drugs for the prevention or treatment of human diseases; Scientific research in the field of drug discovery and development for others; Biomedical research services; Scientific research; Preclinical development of therapeutic product |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 4, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | FORESITE CAPITAL MANAGEMENT, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Larkspur, CA 94939 |
Trademark Events
| Event Date | Event Description |
| Wednesday, September 4, 2024 | NEW APPLICATION ENTERED |
| Sunday, March 16, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Sunday, March 16, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 17, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, March 18, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 18, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 18, 2025 | NON-FINAL ACTION WRITTEN |
